All In Biotech

Free tool

FAERS Monitor: Selzentry

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022128 or its brand name (Selzentry, Maraviroc). Reports on generic versions are filed under their own applications.

Reports

2,293

Serious

1,961

86% of reports

Hospitalization

825

Death reported

264

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • virologic failure141
  • viral mutation identified128
  • pathogen resistance125
  • pain95
  • anxiety94
  • off label use94
  • drug ineffective93
  • drug interaction86
  • drug resistance85
  • emotional distress73
  • nausea73
  • treatment failure64
  • anhedonia62
  • exposure during pregnancy62
  • treatment noncompliance57

Reports by year received

View as table
YearReports
200711
200886
2009151
2010164
2011138
2012156
2013124
2014120
2015140
2016185
2017133
2018128
2019108
2020118
2021140
2022120
2023124
202464
202549
202634

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,866 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
viral mutation identifiedSignal128330.2278.240,241
virologic failureSignal141246.9210.033,403
pathogen resistanceSignal125127.5107.415,359
drug resistanceSignal8530.524.72,387
anhedoniaSignal6221.717.01,202
treatment noncomplianceSignal579.67.4429
exposure during pregnancySignal629.27.2443
treatment failureSignal647.15.6330
emotional distressSignal735.54.4268
drug interactionSignal865.04.0271
anxietySignal943.02.5128
pain951.41.212
off label use941.00.80
nausea730.80.72
drug ineffective930.60.519

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.